FLOYD ERIC purchased 126.6% of their position (4.48K shares) of VIRPAX PHARMACEUTICALS, INC. on the open market
Open‑market purchase worth $6.1K — a major conviction buy. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 5/20/2022ACC: 0001493152-22-014657
+4.48K
Net shares
Net buyer
$6.1K
Total acquired
1
Open market trades
1B · 0S
1
Total transactions
4.48K acquired
Non-Derivative Transactions1
Common Stock, $0.00001 par value
Direct
Shares
+4.48K
Price / share
$1.36
Trade value
$6.11K
% of position
126.6%
5/18/2022
3.54K→8.02K
Total
Net shares
+4.48K
Net value
$6.11K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock, $0.00001 par value Direct | 5/18/2022 | P · Purchase | +4.48K | $1.36 | $6.11K | 126.6% | 3.54K | 8.02K |
| Total | +4.48K | $6.11K | ||||||
Derivative Transactions0
No derivative transactions reported